191 related articles for article (PubMed ID: 12057044)
1. Gemcitabine in combination with vinorelbine for treatment of advanced breast cancer.
Hortobagyi GN
Clin Breast Cancer; 2002 May; 3 Suppl 1():34-8. PubMed ID: 12057044
[TBL] [Abstract][Full Text] [Related]
2. Treatment of advanced breast cancer with gemcitabine and vinorelbine.
Hortobagyi GN
Oncology (Williston Park); 2001 Feb; 15(2 Suppl 3):15-7. PubMed ID: 11252883
[TBL] [Abstract][Full Text] [Related]
3. Introduction. Single-agent or combination chemotherapy in metastatic breast cancer.
Seidman A
Oncology (Williston Park); 2003 Dec; 17(12 Suppl 14):9-14. PubMed ID: 14768399
[No Abstract] [Full Text] [Related]
4. Gemcitabine combination chemotherapy in metastatic breast cancer: phase II experience.
O'Shaughnessy J
Oncology (Williston Park); 2003 Dec; 17(12 Suppl 14):15-21. PubMed ID: 14768400
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy and toxicity of gemcitabine combined vinorelbine on metastatic breast cancer: a report of 34 cases].
Zhou NN; Teng XY; Jiang WQ; Liu DG
Ai Zheng; 2007 Dec; 26(12):1373-6. PubMed ID: 18076805
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of gemcitabine in combination with vinorelbine versus gemcitabine followed by vinorelbine for metastatic breast cancer.
Park IH; Ro J; Lee KS; Kim SN; Yun YH; Nam BH
Invest New Drugs; 2010 Oct; 28(5):659-69. PubMed ID: 19575146
[TBL] [Abstract][Full Text] [Related]
7. Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial.
Martín M; Ruiz A; Muñoz M; Balil A; García-Mata J; Calvo L; Carrasco E; Mahillo E; Casado A; García-Saenz JA; Escudero MJ; Guillem V; Jara C; Ribelles N; Salas F; Soto C; Morales-Vasquez F; Rodríguez CA; Adrover E; Mel JR;
Lancet Oncol; 2007 Mar; 8(3):219-25. PubMed ID: 17329192
[TBL] [Abstract][Full Text] [Related]
8. The combination of gemcitabine and vinorelbine is an active regimen as second-line therapy in patients with metastatic breast cancer pretreated with taxanes and/or anthracyclines: a phase I-II study.
Morabito A; Filippelli G; Palmeri S; Cascinu S; Ferraù F; Zagonel V; Gattuso D; Catalano V; Capaccetti B; Franciosi V; Accurso V; Scinto F; Gasparini G
Breast Cancer Res Treat; 2003 Mar; 78(1):29-36. PubMed ID: 12611454
[TBL] [Abstract][Full Text] [Related]
9. Role of gemcitabine in the treatment of advanced and metastatic breast cancer.
Heinemann V
Oncology; 2003; 64(3):191-206. PubMed ID: 12697958
[TBL] [Abstract][Full Text] [Related]
10. Second-line neoadjuvant vinorelbine and gemcitabine combination in locally advanced breast cancer showing no early response to TAC.
Halim A; Wahba H
Med Oncol; 2012 Jun; 29(2):454-8. PubMed ID: 21350875
[TBL] [Abstract][Full Text] [Related]
11. A phase II study of gemcitabine combined with vinorelbine as first-line chemotherapy for metastatic breast cancer.
Shehata S; Saad E; Goda Y; El-Mesidi S; Koheil H; Elzawhri H; Kandeel A; Abdelhamid T; Zaki M; Meshref M
Hematol Oncol Stem Cell Ther; 2010; 3(1):1-6. PubMed ID: 20231807
[TBL] [Abstract][Full Text] [Related]
12. Gemcitabine and targeted therapy in metastatic breast cancer.
Qu G; Perez EA
Semin Oncol; 2002 Jun; 29(3 Suppl 11):44-52. PubMed ID: 12138397
[TBL] [Abstract][Full Text] [Related]
13. Gemcitabine and vinorelbine combination in patients with metastatic breast cancer.
Sanal SM; Gokmen E; Karabulut B; Sezgin C
Breast J; 2002; 8(3):171-6. PubMed ID: 12047474
[TBL] [Abstract][Full Text] [Related]
14. [Updates on gemcitabine on metastatic breast cancer].
Gligorov J; Selle F; Khalil A; Abbas F; Namer M; Lotz JP
Bull Cancer; 2007; 94 Spec No Actualites():S90-4. PubMed ID: 17845977
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine as prolonged infusion and vinorelbine in anthracycline and/or taxane pretreated metastatic breast cancer: a phase II study.
Schmid P; Heilmann V; Schulz CO; Dieing A; Lehenbauer-Dehm S; Jehn C; Sezer O; Possinger K; Flath B
J Cancer Res Clin Oncol; 2005 Sep; 131(9):568-74. PubMed ID: 16044345
[TBL] [Abstract][Full Text] [Related]
16. Treatment of advanced breast cancer with gemcitabine and vinorelbine plus human granulocyte colony-stimulating factor.
Haider K; Kornek GV; Kwasny W; Weinländer G; Valencak J; Lang F; Püribauer F; Kovats E; Depisch D; Scheithauer W
Breast Cancer Res Treat; 1999 Jun; 55(3):203-11. PubMed ID: 10517165
[TBL] [Abstract][Full Text] [Related]
17. Rationale for the use of gemcitabine in breast cancer (Review).
Silvestris N; D'Aprile M; Andreola G; Locopo N; Marini L; Crucitta E; De Lena M; Lorusso V
Int J Oncol; 2004 Feb; 24(2):389-98. PubMed ID: 14719116
[TBL] [Abstract][Full Text] [Related]
18. Role of gemcitabine in metastatic breast cancer patients: a short review.
Silvestris N; Cinieri S; La Torre I; Pezzella G; Numico G; Orlando L; Lorusso V
Breast; 2008 Jun; 17(3):220-6. PubMed ID: 18037292
[TBL] [Abstract][Full Text] [Related]
19. Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: a phase II study conducted by the Hellenic Cooperative Oncology Group.
Nicolaides C; Dimopoulos MA; Samantas E; Bafaloukos D; Kalofonos C; Fountzilas G; Razi E; Kosmidis P; Pavlidis N
Ann Oncol; 2000 Jul; 11(7):873-5. PubMed ID: 10997817
[TBL] [Abstract][Full Text] [Related]
20. Biweekly administration of gemcitabine and vinorelbine as first line therapy in elderly advanced breast cancer.
Dinota A; Bilancia D; Romano R; Manzione L
Breast Cancer Res Treat; 2005 Jan; 89(1):1-3. PubMed ID: 15666190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
